SHP2 phosphatase promotes mast cell chemotaxis toward stem cell factor via enhancing activation of the Lyn/Vav/Rac signaling axis

Journal of Immunology

Volumn 192, Issue 10, 2014, Pages 4859-4866

  Sharma, Namit ^a   Everingham, Stephanie ^a   Ramdas, Baskar ^b,c   Kapur, Reuben ^b,c   Craig, Andrew W B ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

F ACTIN; PROTEIN KINASE LYN; PROTEIN TYROSINE PHOSPHATASE SHP 2; STEM CELL FACTOR;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL MOTILITY; CELL PROLIFERATION; CELL SPREADING; CELL SURVIVAL; CELL VIABILITY; CHEMOTAXIS; GENOTYPE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMERIZATION; PROTEIN SECRETION;

ANIMALS; CHEMOTAXIS; ENZYME ACTIVATION; MAST CELLS; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-VAV; SRC-FAMILY KINASES; STEM CELL FACTOR;

EID: 84901264996     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301155     Document Type: Article

References (46)

1. Tsai, M., M. Grimbaldeston, and S. J. Galli. 2011. Mast cells and immunoregulation/ immunomodulation. Adv. Exp. Med. Biol. 716: 186-211.
2. Collington, S. J., T. J. Williams, and C. L. Weller. 2011. Mechanisms underlying the localisation of mast cells in tissues. Trends Immunol. 32: 478-485.
3. Ribatti, D., and E. Crivellato. 2011. Mast cells, angiogenesis and cancer. Adv. Exp. Med. Biol. 716: 270-288.
4. Halova, I., L. Draberova, and P. Draber. 2012. Mast cell chemotaxis - chemoattractants and signaling pathways. Front. Immunol. 3: 119.
5. Reber, L., C. A. Da Silva, and N. Frossard. 2006. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases. Eur. J. Pharmacol. 533: 327-340.
6. Maltby, S., K. Khazaie, and K. M. McNagny. 2009. Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim. Biophys. Acta 1796: 19-26.
7. Lennartsson, J., and L. Rölnnstrand. 2012. Stem cell factor receptor/c-Kit: from basic science to clinical implications. Physiol. Rev. 92: 1619-1649.
8. Da Silva, C. A., F. Blay, D. Israel-Biet, A. M. Laval, N. Glasser, G. Pauli, and N. Frossard. 2006. Effect of glucocorticoids on stem cell factor expression in human asthmatic bronchi. Clin. Exp. Allergy 36: 317-324.
9. Al-Muhsen, S. Z., G. Shablovsky, R. Olivenstein, B. Mazer, and Q. Hamid. 2004. The expression of stem cell factor and c-kit receptor in human asthmatic airways. Clin. Exp. Allergy 34: 911-916.
10. Campbell, E., C. Hogaboam, P. Lincoln, and N. W. Lukacs. 1999. Stem cell factor-induced airway hyperreactivity in allergic and normal mice. Am. J. Pathol. 154: 1259-1265.
11. Olsson, N., S. Rak, and G. Nilsson. 2000. Demonstration of mast cell chemotactic activity in bronchoalveolar lavage fluid collected from asthmatic patients before and during pollen season. J. Allergy Clin. Immunol. 105: 455-461.
12. Huang, B., Z. Lei, G. M. Zhang, D. Li, C. Song, B. Li, Y. Liu, Y. Yuan, J. Unkeless, H. Xiong, and Z. H. Feng. 2008. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 112: 1269-1279.
13. Kwok, E., S. Everingham, S. Zhang, P. A. Greer, J. S. Allingham, and A. W. Craig. 2012. FES kinase promotes mast cell recruitment to mammary tumors via the stem cell factor/KIT receptor signaling axis. Mol. Cancer Res. 10: 881-891.
14. Théou-Anton, N., S. Tabone, D. Brouty-Boyé, R. Saffroy, L. Ronnstrand, A. Lemoine, and J. F. Emile. 2006. Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism. Br. J. Cancer 94: 1180-1185.
15. Zhu, H. H., K. Ji, N. Alderson, Z. He, S. Li, W. Liu, D. E. Zhang, L. Li, and G. S. Feng. 2011. Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool. Blood 117: 5350-5361.
16. Chan, G., L. S. Cheung, W. Yang, M. Milyavsky, A. D. Sanders, S. Gu, W. X. Hong, A. X. Liu, X. Wang, M. Barbara, et al. 2011. Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells. Blood 117: 4253-4261.
17. Sharma, N., V. Kumar, S. Everingham, R. S. Mali, R. Kapur, L. F. Zeng, Z. Y. Zhang, G. S. Feng, K. Hartmann, A. Roers, and A. W. Craig. 2012. SH2 domain-containing phosphatase 2 is a critical regulator of connective tissue mast cell survival and homeostasis in mice. Mol. Cell. Biol. 32: 2653-2663.
18. Yu, M., C. A. Lowell, B. G. Neel, and H. Gu. 2006. Scaffolding adapter Grb2- associated binder 2 requires Syk to transmit signals from FcepsilonRI. J. Immunol. 176: 2421-2429.
19. Ueda, S., M. Mizuki, H. Ikeda, T. Tsujimura, I. Matsumura, K. Nakano, H. Daino, Z. Honda Zi, J. Sonoyama, H. Shibayama, et al. 2002. Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor-induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell migration. Blood 99: 3342-3349.
20. McPherson, V. A., N. Sharma, S. Everingham, J. Smith, H. H. Zhu, G. S. Feng, and A. W. Craig. 2009. SH2 domain-containing phosphatase-2 protein-tyrosine phosphatase promotes FceRI-induced activation of Fyn and Erk pathways leading to TNF a release from bone marrow-derived mast cells. J. Immunol. 183: 4940-4947.
21. Ma, P., S. Vemula, V. Munugalavadla, J. Chen, E. Sims, J. Borneo, T. Kondo, B. Ramdas, R. S. Mali, S. Li, et al. 2011. Balanced interactions between Lyn, the p85a regulatory subunit of class I(A) phosphatidylinositol-3-kinase, and SHIP are essential for mast cell growth and maturation. Mol. Cell. Biol. 31: 4052-4062.
22. Craig, A. W., and P. A. Greer. 2002. Fer kinase is required for sustained p38 kinase activation and maximal chemotaxis of activated mast cells. Mol. Cell. Biol. 22: 6363-6374.
23. Ito, T., D. Smrz, M. Y. Jung, G. Bandara, A. Desai, S. Smrzová, H. S. Kuehn, M. A. Beaven, D. D. Metcalfe, and A. M. Gilfillan. 2012. Stem cell factor programs the mast cell activation phenotype. J. Immunol. 188: 5428-5437.
24. Kontaridis, M. I., S. Eminaga, M. Fornaro, C. I. Zito, R. Sordella, J. Settleman, and A. M. Bennett. 2004. SHP-2 positively regulates myogenesis by coupling to the Rho GTPase signaling pathway. Mol. Cell. Biol. 24: 5340-5352.
25. Samayawardhena, L. A., R. Kapur, and A. W. Craig. 2007. Involvement of Fyn kinase in Kit and integrin-mediated Rac activation, cytoskeletal reorganization, and chemotaxis of mast cells. Blood 109: 3679-3686.
26. Tan, B. L., M. N. Yazicioglu, D. Ingram, J. McCarthy, J. Borneo, D. A.Williams, and R. Kapur. 2003. Genetic evidence for convergence of c-Kit- and a4 integrinmediated signals on class IA PI-3kinase and the Rac pathway in regulating integrin-directed migration in mast cells. Blood 101: 4725-4732.
27. Gilfillan, A. M., and J. Rivera. 2009. The tyrosine kinase network regulating mast cell activation. Immunol. Rev. 228: 149-169.
28. Yu, M., J. Luo, W. Yang, Y. Wang, M. Mizuki, Y. Kanakura, P. Besmer, B. G. Neel, and H. Gu. 2006. The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway. J. Biol. Chem. 281: 28615-28626.
29. O'Laughlin-Bunner, B., N. Radosevic, M. L. Taylor, C. Shivakrupa, C. DeBerry, D. D. Metcalfe, M. Zhou, C. Lowell, and D. Linnekin. 2001. Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells. Blood 98: 343-350.
30. Samayawardhena, L. A., and C. J. Pallen. 2008. Protein-tyrosine phosphatase a regulates stem cell factor-dependent c-Kit activation and migration of mast cells. J. Biol. Chem. 283: 29175-29185.
31. Dance, M., A. Montagner, J. P. Salles, A. Yart, and P. Raynal. 2008. The molecular functions of Shp2 in the Ras/mitogen-activated protein kinase (ERK1/2) pathway. Cell. Signal. 20: 453-459.
32. Futami, M., Q. S. Zhu, Z. L. Whichard, L. Xia, Y. Ke, B. G. Neel, G. S. Feng, and S. J. Corey. 2011. G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase. Blood 118: 1077-1086.
33. Yu, L., W. Min, Y. He, L. Qin, H. Zhang, A. M. Bennett, and H. Chen. 2009. JAK2 and SHP2 reciprocally regulate tyrosine phosphorylation and stability of proapoptotic protein ASK1. J. Biol. Chem. 284: 13481-13488.
34. Alai, M., A. L. Mui, R. L. Cutler, X. R. Bustelo, M. Barbacid, and G. Krystal. 1992. Steel factor stimulates the tyrosine phosphorylation of the protooncogene product, p95vav, in human hemopoietic cells. J. Biol. Chem. 267: 18021-18025.
35. Matsuguchi, T., R. C. Inhorn, N. Carlesso, G. Xu, B. Druker, and J. D. Griffin. 1995. Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GMCSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL. EMBO J. 14: 257-265.
36. del Pozo, M. A., L. S. Price, N. B. Alderson, X. D. Ren, and M. A. Schwartz. 2000. Adhesion to the extracellular matrix regulates the coupling of the small GTPase Rac to its effector PAK. EMBO J. 19: 2008-2014.
37. Charest, P. G., and R. A. Firtel. 2006. Feedback signaling controls leading-edge formation during chemotaxis. Curr. Opin. Genet. Dev. 16: 339-347.
38. McDaniel, A. S., J. D. Allen, S. J. Park, Z. M. Jaffer, E. G. Michels, S. J. Burgin, S. Chen, W. K. Bessler, C. Hofmann, D. A. Ingram, et al. 2008. Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells. Blood 112: 4646-4654.
39. Zhang, X., Y. He, S. Liu, Z. Yu, Z. X. Jiang, Z. Yang, Y. Dong, S. C. Nabinger, L. Wu, A. M. Gunawan, et al. 2010. Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2). J. Med. Chem. 53: 2482-2493.
40. Yang, F. C., R. Kapur, A. J. King, W. Tao, C. Kim, J. Borneo, R. Breese, M. Marshall, M. C. Dinauer, and D. A. Williams. 2000. Rac2 stimulates Akt activation affecting BAD/Bcl-XL expression while mediating survival and actin function in primary mast cells. Immunity 12: 557-568.
41. Zhang, S. Q., W. Yang, M. I. Kontaridis, T. G. Bivona, G. Wen, T. Araki, J. Luo, J. A. Thompson, B. L. Schraven, M. R. Philips, and B. G. Neel. 2004. Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol. Cell 13: 341-355.
42. Kai, M., S. Yasuda, S. Imai, H. Kanoh, and F. Sakane. 2007. Tyrosine phosphorylation of b2-chimaerin by Src-family kinase negatively regulates its Racspecific GAP activity. Biochim. Biophys. Acta 1773: 1407-1415.
43. Wertheimer, E., A. Gutierrez-Uzquiza, C. Rosemblit, C. Lopez-Haber, M. S. Sosa, and M. G. Kazanietz. 2012. Rac signaling in breast cancer: a tale of GEFs and GAPs. Cell. Signal. 24: 353-362.
44. Stewart, R. A., T. Sanda, H. R. Widlund, S. Zhu, K. D. Swanson, A. D. Hurley, M. Bentires-Alj, D. E. Fisher, M. I. Kontaridis, A. T. Look, and B. G. Neel. 2010. Phosphatase-dependent and -independent functions of Shp2 in neural crest cells underlie LEOPARD syndrome pathogenesis. Dev. Cell 18: 750-762.
45. Yu, Z. H., J. Xu, C. D. Walls, L. Chen, S. Zhang, R. Zhang, L. Wu, L. Wang, S. Liu, and Z. Y. Zhang. 2013. Structural and mechanistic insights into LEOPARD syndrome-associated SHP2 mutations. J. Biol. Chem. 288: 10472-10482.
46. Mali, R. S., P. Ma, L. F. Zeng, H. Martin, B. Ramdas, Y. He, E. Sims, S. Nabinger, J. Ghosh, N. Sharma, et al. 2012. Role of SHP2 phosphatase in KITinduced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT. Blood 120: 2669-2678.